<SEC-DOCUMENT>0001410368-16-003245.txt : 20161122
<SEC-HEADER>0001410368-16-003245.hdr.sgml : 20161122
<ACCEPTANCE-DATETIME>20161122163735
ACCESSION NUMBER:		0001410368-16-003245
CONFORMED SUBMISSION TYPE:	NSAR-B
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20160930
FILED AS OF DATE:		20161122
DATE AS OF CHANGE:		20161122
EFFECTIVENESS DATE:		20161122

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TEKLA HEALTHCARE INVESTORS
		CENTRAL INDEX KEY:			0000805267
		IRS NUMBER:				046564285
		STATE OF INCORPORATION:			MA
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		NSAR-B
		SEC ACT:		1940 Act
		SEC FILE NUMBER:	811-04889
		FILM NUMBER:		162013605

	BUSINESS ADDRESS:	
		STREET 1:		100 FEDERAL STREET
		STREET 2:		19TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02110
		BUSINESS PHONE:		6177728515

	MAIL ADDRESS:	
		STREET 1:		100 FEDERAL STREET
		STREET 2:		19TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02110

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	H&Q HEALTHCARE INVESTORS
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>NSAR-B
<SEQUENCE>1
<FILENAME>answ..fil
<DESCRIPTION>NSAR-B
<TEXT>
<PAGE>      PAGE  1
000 B000000 09/30/2016
000 C000000 0000805267
000 D000000 N
000 E000000 NF
000 F000000 Y
000 G000000 N
000 H000000 N
000 I000000 6.1
000 J000000 A
001 A000000 TEKLA HEALTHCARE INVESTORS
001 B000000 811-4889
001 C000000 6177728500
002 A000000 100 Federal Street, 19th Floor
002 B000000 BOSTON
002 C000000 MA
002 D010000 02110
003  000000 N
004  000000 N
005  000000 N
006  000000 N
007 A000000 N
007 B000000  0
007 C010100  1
008 A000001 TEKLA CAPITAL MANAGEMENT LLC
008 B000001 A
008 C000001 801-000000
008 D010001 BOSTON
008 D020001 MA
008 D030001 02110
010 A000001 STATE STREET BANK AND TRUST CO.
010 B000001 85-85003
010 C010001 BOSTON
010 C020001 MA
010 C030001 02111
012 A000001 COMPUTERSHARE TRUST CO. N.A.
012 B000001 85-113400
012 C010001 CANTON
012 C020001 MA
012 C030001 02021
013 A000001 DELOITTE & TOUCHE LLP
013 B010001 BOSTON
013 B020001 MA
013 B030001 02110
015 A000001 STATE STREET BANK & TRUST CO.
015 B000001 C
015 C010001 BOSTON
015 C020001 MA
015 C030001 02110
015 E010001 X
018  000000 Y
019 A000000 Y
<PAGE>      PAGE  2
019 B000000    4
019 C000000 TEKLAFUNDS
020 A000001 NATIONAL FINANCIAL SERVICES CORP.
020 B000001 04-2785576
020 C000001     67
020 A000002 JPMORGAN CHASE & CO.
020 B000002 13-3224013
020 C000002     58
020 A000003 BANK OF NEW YORK MELLON
020 B000003 13-5160382
020 C000003     58
020 A000004 MIZUHO CORPORATE BANK LTD.
020 B000004 13-5624234
020 C000004     25
020 A000005 WELLS FARGO SECURITIES, LLC
020 B000005 56-2326000
020 C000005     24
020 A000006 JEFFERIES & CO.
020 B000006 95-2622900
020 C000006     20
020 A000007 BANK OF AMERICA CORP.
020 B000007 95-4035346
020 C000007     19
020 A000008 MORGAN STANLEY
020 B000008 13-2665598
020 C000008     18
020 A000009 STIFEL NICOLAUS & CO. INC.
020 B000009 43-0538770
020 C000009     15
020 A000010 BARCLAYS BANK PLC
020 B000010 13-3551367
020 C000010      9
021  000000      348
022 A000001 STATE STREET BANK AND TRUST CO.
022 B000001 04-1867445
022 C000001   9021814
022 D000001         0
022 A000002 AFFERENT PHARMACEUTICALS
022 C000002      2621
022 D000002      9356
022 A000003 JEFFERIES & CO.
022 B000003 95-2622900
022 C000003      1300
022 D000003      4349
022 A000004 JPMORGAN CHASE & CO.
022 B000004 13-3224013
022 C000004      5000
022 D000004         0
022 A000005 BANK OF AMERICA CORP.
022 B000005 95-4035346
022 C000005      4390
<PAGE>      PAGE  3
022 D000005         0
022 A000006 GENOMEDX BIOSCEINCES, INC.
022 C000006      4000
022 D000006         0
022 A000007 MAGELLAN DIAGNOSTICS, INC.
022 C000007         0
022 D000007      2878
022 A000008 BANK OF NEW YORK MELLON
022 B000008 13-5160382
022 C000008      1800
022 D000008         0
022 A000009 ILLUMINOSS MEDICAL, INC
022 C000009      1050
022 D000009         0
022 A000010 BIOCLIN THERAPEUTICS, INC.
022 C000010      1010
022 D000010         0
023 C000000    9043922
023 D000000      16584
024  000000 N
025 D000001       0
025 D000002       0
025 D000003       0
026 A000000 N
026 B000000 Y
026 C000000 N
026 D000000 Y
026 E000000 N
026 F000000 N
026 G010000 N
026 G020000 N
026 H000000 N
027  000000 N
028 A010000         0
028 A020000         0
028 A030000         0
028 A040000         0
028 B010000         0
028 B020000         0
028 B030000         0
028 B040000         0
028 C010000         0
028 C020000         0
028 C030000         0
028 C040000         0
028 D010000         0
028 D020000         0
028 D030000         0
028 D040000         0
028 E010000         0
028 E020000         0
<PAGE>      PAGE  4
028 E030000         0
028 E040000         0
028 F010000         0
028 F020000         0
028 F030000         0
028 F040000         0
028 G010000         0
028 G020000         0
028 G030000         0
028 G040000         0
028 H000000         0
030 A000000      0
030 B000000  0.00
030 C000000  0.00
031 A000000      0
031 B000000      0
032  000000      0
033  000000      0
035  000000      0
036 B000000      0
038  000000      0
042 A000000   0
042 B000000   0
042 C000000   0
042 D000000   0
042 E000000   0
042 F000000   0
042 G000000   0
042 H000000   0
043  000000      0
044  000000      0
045  000000 Y
046  000000 N
047  000000 N
048  000000  0.000
048 A010000        0
048 A020000 0.000
048 B010000        0
048 B020000 0.000
048 C010000        0
048 C020000 0.000
048 D010000        0
048 D020000 0.000
048 E010000        0
048 E020000 0.000
048 F010000        0
048 F020000 0.000
048 G010000        0
048 G020000 0.000
048 H010000        0
048 H020000 0.000
<PAGE>      PAGE  5
048 I010000        0
048 I020000 0.000
048 J010000        0
048 J020000 0.000
048 K010000        0
048 K020000 0.000
049  000000 N
050  000000 N
051  000000 N
052  000000 N
053 A000000 N
054 A000000 Y
054 B000000 N
054 C000000 Y
054 D000000 N
054 E000000 N
054 F000000 N
054 G000000 N
054 H000000 N
054 I000000 N
054 J000000 Y
054 K000000 N
054 L000000 N
054 M000000 Y
054 N000000 N
054 O000000 N
055 A000000 N
055 B000000 N
056  000000 N
057  000000 N
058 A000000 N
059  000000 Y
060 A000000 Y
060 B000000 N
061  000000        0
062 A000000 N
062 B000000   0.0
062 C000000   0.0
062 D000000   0.0
062 E000000   0.0
062 F000000   0.0
062 G000000   0.0
062 H000000   0.0
062 I000000   0.0
062 J000000   0.0
062 K000000   0.0
062 L000000   0.0
062 M000000   0.0
062 N000000   0.0
062 O000000   0.0
062 P000000   0.0
<PAGE>      PAGE  6
062 Q000000   0.0
062 R000000   0.0
063 A000000   0
063 B000000  0.0
066 A000000 Y
066 B000000 N
066 C000000 Y
066 D000000 N
066 E000000 N
066 F000000 N
066 G000000 N
067  000000 N
068 A000000 N
068 B000000 N
069  000000 N
070 A010000 Y
070 A020000 Y
070 B010000 Y
070 B020000 N
070 C010000 N
070 C020000 N
070 D010000 Y
070 D020000 N
070 E010000 N
070 E020000 N
070 F010000 Y
070 F020000 N
070 G010000 Y
070 G020000 N
070 H010000 Y
070 H020000 N
070 I010000 N
070 I020000 N
070 J010000 Y
070 J020000 Y
070 K010000 Y
070 K020000 Y
070 L010000 Y
070 L020000 Y
070 M010000 Y
070 M020000 N
070 N010000 Y
070 N020000 N
070 O010000 Y
070 O020000 N
070 P010000 N
070 P020000 N
070 Q010000 N
070 Q020000 N
070 R010000 Y
070 R020000 N
<PAGE>      PAGE  7
071 A000000    286639
071 B000000    343816
071 C000000    973674
071 D000000   29
072 A000000 12
072 B000000       62
072 C000000     4739
072 D000000        0
072 E000000        0
072 F000000     9469
072 G000000      206
072 H000000        0
072 I000000       56
072 J000000      138
072 K000000      258
072 L000000       46
072 M000000      141
072 N000000        0
072 O000000        0
072 P000000        0
072 Q000000        0
072 R000000      109
072 S000000      102
072 T000000      361
072 U000000        0
072 V000000        0
072 W000000      198
072 X000000    11084
072 Y000000        0
072 Z000000    -6283
072AA000000    50259
072BB000000        0
072CC010000        0
072CC020000    99995
072DD010000        0
072DD020000        0
072EE000000   116918
073 A010000   0.0000
073 A020000   0.0000
073 B000000   3.1000
073 C000000   0.0000
074 A000000        1
074 B000000    48620
074 C000000        0
074 D000000      808
074 E000000    36492
074 F000000   893911
074 G000000        0
074 H000000        0
074 I000000    19314
074 J000000     9488
<PAGE>      PAGE  8
074 K000000        0
074 L000000      119
074 M000000      823
074 N000000  1009576
074 O000000    33725
074 P000000      752
074 Q000000        0
074 R010000        0
074 R020000        0
074 R030000        0
074 R040000      316
074 S000000        0
074 T000000   974783
074 U010000    39004
074 U020000        0
074 V010000    24.99
074 V020000     0.00
074 W000000   0.0000
074 X000000      414
074 Y000000        0
075 A000000        0
075 B000000  1010598
076  000000    23.81
077 A000000 Y
077 B000000 Y
077 C000000 Y
077 D000000 N
077 E000000 N
077 F000000 N
077 G000000 N
077 H000000 N
077 I000000 N
077 J000000 N
077 K000000 N
077 L000000 N
077 M000000 N
077 N000000 N
077 O000000 N
077 P000000 N
077 Q010000 N
077 Q020000 N
077 Q030000 N
078  000000 N
080 A000000 ICI MUTUAL INSURANCE COMPANY
080 C000000     3900
081 A000000 Y
081 B000000   4
082 A000000 Y
082 B000000       25
083 A000000 N
083 B000000        0
<PAGE>      PAGE  9
084 A000000 N
084 B000000        0
085 A000000 Y
085 B000000 N
086 A010000      0
086 A020000      0
086 B010000   1706
086 B020000  43363
086 C010000      0
086 C020000      0
086 D010000      0
086 D020000      0
086 E010000      0
086 E020000      0
086 F010000      0
086 F020000      0
087 A010000 TEKLA HEALTHCARE INVESTORS
087 A020000 87911J103
087 A030000 HQH
088 A000000 N
088 B000000 N
088 C000000 N
088 D000000 N
SIGNATURE   LAURA WOODWARD
TITLE       TREASURER

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.77B ACCT LTTR
<SEQUENCE>2
<FILENAME>hqhnsarletter77b.txt
<DESCRIPTION>EXHIBIT 77B
<TEXT>
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Shareholders and Board of Trustees of Tekla Healthcare Investors

In planning and performing our audit of the financial statements of
Tekla Healthcare Investors (the Fund) as of and for the year ended
September 30, 2016 in accordance with the standards of the Public
Company Accounting Oversight Board (United States), we considered the
Funds internal control over financial reporting, including controls
over safeguarding securities, as a basis for designing our auditing
procedures for the purpose of expressing our opinion on the financial
statements and to comply with the requirements of Form N-SAR, but not
for the purpose of expressing an opinion on the effectiveness of the
Funds internal control over financial reporting. Accordingly, we
express no such opinion.

The management of the Fund is responsible for establishing and
maintaining effective internal control over financial reporting.
In fulfilling this responsibility, estimates and judgments by
management are required to assess the expected benefits and related
costs of controls. A funds internal control over financial reporting
is a process designed to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with generally accepted
accounting principles. A funds internal control over financial
reporting includes those policies and procedures that (1) pertain to
the maintenance of records that, in reasonable detail, accurately
and fairly reflect the transactions and dispositions of the assets of
the fund; (2) provide reasonable assurance that transactions are
recorded as necessary to permit preparation of financial statements
in accordance with generally accepted accounting principles, and that
receipts and expenditures of the fund are being made only in
accordance with authorizations of management and trustees of
the fund; and (3) provide reasonable assurance regarding prevention
or timely detection of unauthorized acquisition, use, or disposition
of a fund's assets that could have a material effect on the
financial statements.

Because of its inherent limitations, internal control over financial
reporting may not prevent or detect misstatements. Also, projections
of any evaluation of effectiveness to future periods are subject to
the risk that controls may become inadequate because of changes in
conditions or that the degree of compliance with the
policies or procedures may deteriorate.

A deficiency in internal control over financial reporting exists
when the design or operation of a control does not allow management
or employees, in the normal course of performing their assigned
functions, to prevent or detect misstatements on a timely basis.
A material weakness is a deficiency, or a combination of deficiencies,
in internal control over financial reporting, such that there is a
reasonable possibility that a material misstatement of
the funds annual or interim financial statements will not be
prevented or detected on a timely basis.

Our consideration of the Funds internal control over financial
reporting was for the limited purpose described in the first
paragraph and would not necessarily disclose all deficiencies in
internal control that might be material weaknesses under
standards established by the Public Company Accounting Oversight
Board (United States). However, we noted no deficiencies in the
Funds internal control over financial reporting and its operation,
including controls for safeguarding securities that we consider to
be a material weakness, as defined above, as of September 30, 2016.

This report is intended solely for the information and use of
management and the Trustees of Tekla Healthcare Investors and the
Securities and Exchange Commission and is not intended to be and
should not be used by anyone other than these specified parties.

DELOITTE & TOUCHE LLP
Boston, Massachusetts
November 18, 2016






</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.77C VOTES
<SEQUENCE>3
<FILENAME>hqhvotingresults.txt
<DESCRIPTION>EXHIBIT 77C
<TEXT>
An Annual Meeting of Shareholders was held on June 14, 2016.
Shareholders voted to elect Trustees of the Fund to hold office
for a term of three years or until their respective successors
shall have been duly elected and qualified. The following votes
were cast with respect to each of the nominees:

                             		For           Withheld
Michael W. Bonney        	     19,980,702        583,546
Oleg M. Pohotsky, M.B.A., J.D.       19,835,219        729,029
William S. Reardon, CPA              19,974,900        589,348

Michael W. Bonney, William S. Reardon, CPA and Oleg M. Pohotsky M.B.A.,
J.D. were elected to serve until the 2019 Annual Meeting.

Trustees serving until the 2017 Annual Meeting are Rakesh K. Jain, Ph.D.,
and Lucinda H. Stebbins, CPA.

Trustee serving until the 2018 Annual Meeting is Uwe E. Reinhardt, Ph.D.
and Daniel R. Omstead, Ph.D.

Shareholders ratified the appointment of Deloitte & Touche LLP as the
independent registered public accountants of the Fund for the fiscal year
ending September 30, 2016 by the following votes:

		For       Against/Withhold       Abstain
            20,000,318         283,092           280,837



Shareholders approved the change of the sub-classification of the Fund
from diversified to non-diversified by the following votes:

              For        Against/Withhold       Abstain    Broker non-votes
           15,075,990         1,022,787          337,432        4,128,038



Shareholders approved the amendment to the Funds fundamental investment
restriction regarding issuing senior securities by the following votes:

              For        Against/Withhold       Abstain    Broker non-votes
          14,760,633	    1,313,861	         361,715       4,128,038




Shareholders approved the amendment to the Funds fundamental investment
restriction regarding investments in other investment companies by the
following votes:


             For        Against/Withhold        Abstain    Broker non-votes
          14,434,627	    1,643,439	        358,143	       4,128,038




Shareholders approved the amendment to the Funds fundamental investment
restriction regarding short sales and purchasing securities on margin
by the following votes:


            For        Against/Withhold        Abstain     Broker non-votes
        13,945,503          2,120,564	       370,141	      4,128,038







</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
